Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal <scp>RNA</scp> synthesis in non‐small cell lung cancer-Reference-Cited by-同舟云学术

Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synthesis in non‐small cell lung cancer

Published:2022-12-20 Issue:4 Volume:114 Page:1740-1756
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Li Minglei¹^ORCID,Zhang Jiaxi¹,Meng Xue¹,Liu Bei¹,Xie Shelly M.¹,Liu Fang¹,Yao Demin¹,Zhang Jingguo¹,Shen Haitao¹²^ORCID,Xing Lingxiao¹²^ORCID

Affiliation:

1. Department of Pathology Hebei Medical University Shijiazhuang China

2. Center of Metabolic Diseases and Cancer Research Institute of Medical and Health Science, Hebei Medical University Shijiazhuang China

Funder

Hebei Provincial Department of Bureau of Science and Technology

National Natural Science Foundation of China

Natural Science Foundation of Hebei Province

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15687

Reference58 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Non-small-cell lung cancers: a heterogeneous set of diseases

3. Cancer treatment and survivorship statistics, 2019

4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

5. Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting anoikis resistance as a strategy for cancer therapy;Drug Resistance Updates;2024-07